LAUSANNE, Zwitserland & LONDEN & MURRAY HILL, N.J.--(BUSINESS WIRE)--ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary ADCs targeting major cancers, today announced that it has raised $80 million